
    
      32 healthy subjects wil be randomized one of 2 groups in the same ratio. Subjects in group 1
      will be administered "comparator" and "YHP1903" by cross-over design on day1, 8.

      Subjects in group 2 will be administered "YHP1903" and "comparator" by cross-over design on
      day1, 8.
    
  